3-氯苯乙醇 | 41904-40-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-氯苯乙醇
• 中文别名: 3-氯苯乙醛
• 英文名称: 2-(3-chlorophenyl)acetaldehyde
• 英文别名: 3-chlorophenylacetaldehyde
• CAS: 41904-40-9
• 化学式: C₈H₇ClO
• mdl: MFCD02261731
• 分子量: 154.596
• InChiKey: CNBOFJGDTDMTEX-UHFFFAOYSA-N

物化性质

• 沸点：
  135-137 °C13 mm Hg(lit.)
• 密度：
  1.181 g/mL at 25 °C(lit.)
• 闪点：
  >230 °F

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  10
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 安全说明：
  S23,S24/25
• WGK Germany：
  3
• 海关编码：
  2913000090
• 危险性防范说明：
  P264,P302+P352,P304+P340,P305+P351+P338,P332+P313,P337+P313
• 危险性描述：
  H315,H319,H335
• 储存条件：
  室温

反应信息

• 作为反应物：
  描述：

  3-氯苯乙醇 在 rat hepatic microsomal aldehyde dehydrogenase 、 β-烟酰胺腺嘌呤二核苷酸 作用下， 以 phosphate buffer 、 N,N-二甲基甲酰胺 为溶剂， 生成 3-氯苯乙酸
  参考文献：
  名称：

  Rat Hepatic Microsomal Aldehyde Dehydrogenase. Identification of 3- and 4-Substituted Aromatic Aldehydes as Substrates of the Enzyme

  摘要：

  The rat hepatic microsomal aldehyde dehydrogenase (mALDH) metabolizes aliphatic and aromatic aldehydes to the corresponding acids with NAD as the optimal cofactor. However, dehydrogenation of the aliphatic compounds is substantially more efficient. In the present study, a series of aromatic aldehydes was evaluated as substrates of the purified mALDH so that the physicochemical factors that contribute to substrate affinity could be evaluated. Substitution of the aromatic system in the 3- and 4-positions produced relatively good substrates, but 2-substituted congeners did not undergo dehydrogenation. However, aldehydes with hydrophilic substituents in the 3- or 4-positions and those with extremely bulky substituents at both positions (e.g., 3,4-dibenzyloxy) were also poor substrates for the enzyme and dehydrogenation was undetectable. A quantitative structure-activity relationship was determined that related the logarithm of the Michaelis constants for 27 substituted aromatic aldehydes with the zero-order connectivity function of the molecule ((0) chi), the shapes of the 3- and 4-substituents (kappa), and the electronic nature of the 4-substituent (sigma). In this equation, 81% of the data variance was explained. From a consideration of the dimensions of 3-phenoxybenzaldehyde, which was a relatively good substrate, the mALDH possesses a narrow cleft within the active site that is at least 7.5 Angstrom wide and extends at least 12 Angstrom from the the catalytic residue (probably cysteine). Previously established relationships between connectivity functions and molecular polarizability suggest that dipolar interactions within the active site, as well as dispersion forces, may play a role in substrate specificity. Although optimal shapes for carbocyclic substituents were not provided by the analysis, the unfavorable effect on dehydrogenation from hydrophilic and large substituents suggests that the active site of the mALDH is relatively rigid and that the orientation of the substrate in relation to the catalytic cysteine and the cofactor binding site is critical.

  DOI：

  10.1021/tx950106l
• 作为产物：
  描述：

  3-氯苯乙烯 在 chloro[5,10,15,20-tetrakis(4-dimethylamino-2,3,5,6-tetrafluorophenyl)porphyrinate]iron(III) 、 双氧水 、 silver trifluoromethanesulfonate 作用下， 以 1,4-二氧六环 、 水 为溶剂， 以70%的产率得到3-氯苯乙醇
  参考文献：
  名称：

  [Fe（III）（TF4DMAP）OTf]催化末端芳基烯烃反马氏化学氧化为醛，并以H2O2作为末端氧化剂将甲基芳基叔胺转化为甲酰胺。

  摘要：

  使用[Fe（III）（TF4DMAP）OTf]可以中等程度地获得良好的收率，从而在温和的条件下实现了末端芳基烯烃抗马尔科夫尼科夫氧化为醛类以及将N-甲基芳基叔胺转化为甲酰胺并以H2O2作为末端氧化剂的方法。作为催化剂。

  DOI：

  10.1039/c4cc05972g

文献信息

• PROTEIN KINASE INHIBITORS
  申请人：Sheppard S. George

  公开号：US20070203143A1

  公开（公告）日：2007-08-30

  Compounds that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed.

  抑制蛋白激酶的化合物、含有这些化合物的组合物以及利用这些化合物治疗疾病的方法被披露。
• [EN] INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION<br/>[FR] INHIBITEURS DE LA RÉPLICATION DE NOROVIRUS ET DE CORONAVIRUS
  申请人：COCRYSTAL PHARMA INC

  公开号：WO2021206876A1

  公开（公告）日：2021-10-14

  Compounds of Formula (I) and methods of inhibiting the replication of viruses in a biological sample or patient, of reducing the amount of viruses in a biological sample or patient, and of treating a virus infection in a patient, comprising administering to said biological sample or patient an effective amount of a compound represented by Formula (I), a compound of Table A or B or a pharmaceutically acceptable salt thereof.

  公式（I）化合物及抑制生物样本或患者中病毒复制、减少生物样本或患者中病毒数量、以及治疗患者病毒感染的方法，包括向所述生物样本或患者投与由公式（I）表示的化合物、表A或B中的化合物或其药用可接受盐的有效量。
• [EN] RETINOID-RELATED ORPHAN RECEPTOR GAMMA MODULATORS, COMPOSITION CONTAINING THEM AND USES THEREOF<br/>[FR] MODULATEURS DES RÉCEPTEURS ORPHELINS GAMMA APPARENTÉS AU RÉCEPTEUR DES RÉTINOÏDES, COMPOSITION LES CONTENANT ET UTILISATIONS ASSOCIÉES
  申请人：GLAXO GROUP LTD

  公开号：WO2012100732A1

  公开（公告）日：2012-08-02

  Provided are retinoid-related orphan receptor gamma(ROR γ) modulators of formula (I), processes for their preparation, pharmaceutical compositions containing them, and their uses in the treatment of diseases mediated by ROR γ.

  提供了公式（I）的与视黄醛相关孤儿受体γ（ROR γ）调节剂，它们的制备方法，含有它们的药物组合物，以及它们在治疗由ROR γ介导的疾病中的用途。
• [EN] COMBINATION THERAPY USING A BETA 3 ADRENERGIC RECEPTOR AGONIST AND AN ANTIMUSCARINIC AGENT<br/>[FR] POLYTHÉRAPIE UTILISANT UN AGONISTE DES RÉCEPTEURS ADRÉNERGIQUES BÊTA-3 ET UN AGENT ANTIMUSCARINIQUE
  申请人：MERCK SHARP & DOHME

  公开号：WO2011043942A1

  公开（公告）日：2011-04-14

  Described herein is an improved method of treating overactive bladder, wherein the method comprises administering to a patient in need thereof a beta 3 adrenergic receptor agonist, an antimuscarinic agent, and an optional selective M2 antagonist. Such combination therapy provides improved efficacy and/or reduced side effects.

  本文描述了一种改进的治疗过度活跃膀胱的方法，其中该方法包括向需要的患者施用β3肾上腺能受体激动剂、抗胆碱药物和可选的选择性M2拮抗剂。这种联合疗法提供了改善的疗效和/或减少的副作用。
• Two-way homologation of aliphatic aldehydes: Both one-carbon shortening and lengthening via the same intermediate
  作者：Jae Won Yoo、Youngran Seo、Jong Beom Park、Young Gyu Kim

  DOI：10.1016/j.tet.2019.130883

  日期：2020.2

  Aliphatic aldehydes can be homologated to both one-carbon shorter and one-carbon longer homologous carbonyl compounds through the 2–4 steps of reactions via the same intermediates, β,γ-unsaturated α-nitrosulfones, prepared from the proline-catalyzed sequential reactions of several aliphatic aldehydes with phenylsulfonylnitromethane. While the oxidative cleavage of the key intermediates gave one-carbon

  脂肪醛可通过相同的中间体β，γ-不饱和α-硝基砜，经脯氨酸催化的连续反应制备的相同中间体，通过2–4个反应，与一碳短和一碳长的同源羰基化合物同源。几种脂肪醛与苯磺酰基硝基甲烷。当关键中间体的氧化裂解得到一碳较少的同源羰基化合物时，相同关键中间体的还原随后被氧化产生了更多一碳的同源羰基化合物。